The Open Targets Blog

OCTOBER 24, 2023

OMass Therapeutics is using a new technology platform to develop treatments for rare immunological and genetic diseases with high unmet patient needs. We primarily work on immune system diseases, integrating data and analyses from OTG on a large scale. However, the API presented two challenges. Why did you decide to share this openly?

Bioinformatics 63

Bioinformatics Packaging Pharmaceutical Companies Pharma Companies 63

PPD

JULY 13, 2023

At the beginning of 2023, the PPD clinical research business of Thermo Fisher Scientific surveyed 120 drug developers across the pharmaceutical, biopharmaceutical and biotechnology sectors (referred to collectively as “pharma”) to learn more about sponsors’ current needs for site and patient recruitment services.

Clinical Trials 52

Clinical Trials Pharma Companies Trials Clinical Research 52

The Pharma Data

JANUARY 17, 2021

Alzheimer’s disease has found itself in the top three most expensive diseases. Connecticut-based Biohaven Pharmaceuticals was looking pretty hopeful with its third-generation prodrug to modulate glutamate, the most abundant excitatory neurotransmitter in the human body. Vlad Coric, M.D., ” .

Pharma Companies 52

Pharma Companies Disease Treatment Trials 52

Drug Target Review

JULY 11, 2024

Scientists and, increasingly, biotechs and pharma companies hope to create a more detailed map of the surfaceome, the entire cancer cell surface and its membrane-bound proteins. Selecting protein target candidates The DISCO team has a number of global SCLC experts, having published more than 100 papers collectively on the disease.

Therapies 56

Therapies RNA Pharma Companies Disease 56

ACTO

NOVEMBER 25, 2024

“Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. … Generative AI Generative AI (GenAI) refers to systems capable of creating new content, such as images, music, and text.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Pharmaceuticals 52

The Pharma Data

DECEMBER 11, 2020

Find out below how Thermo Fisher Scientific and the University of Oxford are working together to combat the Covid-19 pandemic and discover how pharmaceutical logistics companies are preparing for vaccine distribution. Thermo Fisher Scientific gains CE Mark Certification for its Covid-19 test. Source link.

Vaccine 52

Vaccine Immune Response Pharma Companies Virus 52

Alta Sciences

MARCH 27, 2024

As if that isn’t enough, she is also working toward her PhD, with research focusing on the impact of supramental awareness on disease prevention, healing, and health. At this same time, a large pharmaceutical company invited our graduating class to a retreat where they introduced us to their different departments.

Drug Development 52

Drug Development Medical Schools Pharma Companies Drugs 52

Drug Target Review

OCTOBER 1, 2024

Following clinical practice, I transitioned to the world of pharmaceutical companies which also had its challenges as I had to learn everything from scratch and use my experience and knowledge differently. Being a doctor means giving courage and hope day in, day out to those experiencing illness.

Doctors 97

Doctors Therapies Science Pharma Companies 97

The Pharma Data

JANUARY 31, 2021

At DeveloGen, Dr Dohrmann led the company to become an internationally recognised leader in metabolic diseases. Furthermore, Evotec developed innovative partnership models with academia, biotech and pharma companies to accelerate the translation of academic discoveries into promising co-owned product opportunities.

Science 52

Science Government Medical Schools International 52

Codon

FEBRUARY 13, 2024

alone, according to the Centers for Disease Control and Prevention. 3 Another considerable obstacle to pharmaceutical companies’ interest (and investment) is the fact that for a product to be patentable — and therefore profitable — it has to be considered new and inventive.

Therapies 125

Therapies Virus DNA Clinical Trials 125

The Pharma Data

DECEMBER 23, 2020

AIM announced in October that the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) clinical trial received IRB approval to include patients previously diagnosed with SARS-CoV-2 – which causes the disease COVID-19 – but who now demonstrate post-acute infection chronic fatigue-like symptoms. See: PLOS ONE ). AIM CEO Thomas K.

Clinical Trials 52

Clinical Trials Trials Virus Therapies 52

Vial

MARCH 1, 2024

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). It ensures regulatory compliance for over 15 long-term post-authorization safety studies across eight disease indications. By geographical region, the global CRO services market in 2023 was dominated by North America.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

Elrig

APRIL 29, 2024

His current research concerns the use of quantum chemistry and machine learning to understand chemical reactivity, with the aim of providing insights into the most widely used reaction classes in pharmaceutical synthesis and enabling chemists to design and optimise new synthetic routes to molecules. big pharma or startups/spin off?

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

The Pharma Data

DECEMBER 17, 2020

Hartfield previously served as CEO of Vitae Pharmaceuticals prior to its acquisition by Allergan. X4 Pharmaceuticals – Diego Cadavid was named chief medical officer of Boston-based X4 Pharmaceuticals. Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs.

Small Molecule 52

Small Molecule Engineering Clinical Development Pharmaceuticals 52

Advarra

JULY 19, 2022

The sponsor is the pharmaceutical company conducting the trial. A: Working in a pharmaceutical company is the best way to learn this. Each company will have its own processes, but they will all have the same result. The sponsor-initiated IND is conducted by a pharma company seeking commercial approval.

Packaging 52

Packaging FDA Trials Regulations 52

Vial

FEBRUARY 19, 2024

Explore the groundbreaking VersAptx bioconjugation platform, designed to elevate cancer therapies and uncover the delicate balance between clinical excellence and commercial viability in the dynamic landscape of pharmaceuticals. They eventually succumbed to the disease for multiple reasons. BTK made a difference.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

The Anticancer Fund

JUNE 7, 2022

Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib Published in Pharmaceutical Research This paper reports on an innovative way for using existing non-cancer drugs to reduce the dose and to potentially improve efficacy of approved expensive anticancer drugs.

Clinical Trials 40

Clinical Trials Drugs Trials Treatment 40

The Pharma Data

JANUARY 24, 2021

.–( BUSINESS WIRE )– Faze Medicines , a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced that it has appointed Philip Vickers, Ph.D., Dr. Vickers has over 30 years of experience as a researcher and leader in the pharmaceutical industry.

Pharma Companies 52

Pharma Companies Small Molecule Science Disease 52

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. What is a value-added medicine?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

The Pharma Data

OCTOBER 14, 2020

AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. All jobs have been maintained and the workforce has grown from about 220 to 350. AOP anticipates new opportunities in Austria as a hub for research and business.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Therapies 52

H1 Blog

DECEMBER 11, 2024

Drug Pricing, Global Diversity Strategies, & Emerging AI Applications Each year, we compile our predictions to provide life sciences, pharmaceutical, and healthcare organizations with a comprehensive look at emerging industry trends and dynamics to help them prepare for the year ahead.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

The Pharma Data

NOVEMBER 16, 2020

When taken on its own, the polypill reduced by about 20% the risk of heart attack, stroke, procedures to reopen clogged arteries and other heart disease, the researchers reported. of those who took the polypill alone had a heart attack, stroke, artery-reopening procedure or died of heart disease, compared to 5.5% who took the placebo.

Health Insurance Companies 52

Health Insurance Companies Doctors Medical Schools Pharma Companies 52

Drug Target Review

MAY 23, 2023

Inflammatory bowel disease (IBD) is an umbrella term that describes complex disorders that cause chronic inflammation in the digestive tract with alternating periods of relapse and remission. A changed composition of the gut microbiota is a characteristic trait of inflammatory bowel disease. More than 6.8

Drugs 75

Drugs Small Molecule Production Disease 75

The Pharma Data

MAY 13, 2021

Before I show you what this breakthrough pain solution is, I want to let you in on the “dirty little secret” of the pharmaceutical industry. ” Here’s The Dirty Little Secret Of The Pharmaceutical Industry. Why did the big pharmaceuticals maker under express or hide the potential for addictions with opiates.

Pharmacy 52

Pharmacy Doctors Production Therapies 52

The Pharma Data

DECEMBER 30, 2020

One way or the other, Biogen’s aducanumab for Alzheimer’s disease is likely to be a big story in 2021. In early December 2019, they presented full data at the 12th Clinical Trials on Alzheimer’s Disease (CATD) conference. Four big companies are cited as possible tasty takeover targets for 2021. Deciphera Pharmaceuticals.

Vaccine 52

Vaccine FDA Trials Therapies 52

The Pharma Data

MAY 16, 2021

Adding this “Warrior’s Secret” to your diet will actually decrease your risk of complications from the disease… [8]. Including the pharmaceutical corporation’s wallet-sucking chemical solutions. But with the potent effects of warrior food #2 you can knock out bedroom woes and lower your risk for heart disease and stroke….

Production 52

Production Science Doctors Research 52

ACTO

NOVEMBER 25, 2024

“Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. … Generative AI Generative AI (GenAI) refers to systems capable of creating new content, such as images, music, and text.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Pharmaceuticals 52

Drug Target Review

MARCH 13, 2025

Techbio companies have initiated this approach. Now even non-AI native big pharma companies take a similar view on using clinical genomics with integrated multimodality. About the authors Remco Jan Geukes Foppen , PhD, is an AI and life sciences expert specialising in the pharmaceutical sector.

Drug Development 59

Drug Development Science Clinical Trials FDA 59